Agree, it's hard to see a sharp rebound on the basis of an audit. New investors might trickle in as word gets out. Moving to QB might help, but it looks like a long way off. I doubt insider buying would do much to get the price to the 10 cent level where it belongs.
A physical presence in another venue or an acquisition, I expect would do wonders. I'm not holding my breath, but I am leaving my money where it lies with RXMD.